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S U M M A R Y
Background: Currently, there is no accepted treatment for inoperable bone hydatid disease where
medical treatment has proved ineffective. Alternative treatment strategies are therefore urgently
needed. Radiotherapy may constitute a treatment option, but there is currently a lack of adequate
evidence. This study sought to retrospectively assess the efﬁcacy and safety of surgery or radiotherapy in
the treatment of bone hydatid disease in patients attending a single hospital in China.
Methods: This was a retrospective case series analyzing clinical data from consecutive patients treated
between January 2000 and December 2011. Patients with an Echinococcus sp infection were counselled
about their disease and the potential treatment options, and made an informed decision between
surgery and radiotherapy. All patients were followed up. The treatment outcome was observed in the
two treatment groups based on the frequencies of relapse and complications, and self-evaluated patient
satisfaction.
Results: Of 40 patients (age range 25–57 years), 24 opted for surgery and 16 for radiotherapy. Relapse
occurred in 14 patients (58%) post-surgery and in three patients (21%) post-radiotherapy. Bone defects,
limb movement disorders, and pain were reported in seven patients (29%) post-surgery, while two
patients (13%) reported hardening of the irradiated region or a limb after radiotherapy. Titres of parasite-
speciﬁc antibodies decreased signiﬁcantly after radiotherapy but not after surgical intervention. Patient
satisfaction was signiﬁcantly higher in the radiotherapy group.
Conclusion: This retrospective case series describes, for the ﬁrst time, the clinical outcomes in a series of
patients treated with radiotherapy for bone hydatid disease. Although no direct comparison between the
treatment groups could be made due to methodological limitations of the study design, this study
indicates that well-designed prospective randomized controlled clinical trials assessing radiotherapy
may be warranted in patients with inoperable hydatid disease of the bones.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Bone hydatid disease is most commonly caused by infection
with the tapeworm Echinococcus sp. Among the various tissues
infected by this parasite, bone accounts for 0.5–4.0%, and spinal* Corresponding author. Tel.: +86-13175005186; fax: +86-991-4365444.
E-mail address: medscicl@126.com (H. Wen).
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).hydatid disease accounts for 50–60% of these bone infections.1–3 A
deﬁnitive diagnosis is usually made only at an advanced stage of
disease because the parasites grow very slowly inside bones,3,4 and
diagnosis based on imaging lacks speciﬁcity.3,5–7 Generally, patients
with bone hydatid disease are found to have been in close contact
with sheep or dogs, which serve as natural hosts.1–3,7,8
Bone hydatid disease originates from cancellous bone and
forms a ‘rat hole-like’ lesion by attacking and absorbing local bone,
resulting in pathological fractures. The lesion spreads to the
articular surface, causing pathological dislocation and total jointciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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cancerous growth. There is no periosteal reaction and no new bone
formation, thus there is a high possibility of paralysis, disability,
and death.8
Currently, there is no satisfactory drug with which to treat bone
hydatid disease, and surgery is the most common treatment option,
combined with systemic treatment with albendazole.3,9 Because of
the hardness of bone, the hydatids cannot grow into large spherical
cysts as they do in soft tissues such as the liver or lungs, and do not
have ﬁbrous capsules. The cysts spread to cause bone destruction
and can even puncture cortical bone and erode the surrounding soft
tissues.5 Such characteristics make it very difﬁcult to perform
surgery. During surgery, it is important to protect the surrounding
tissue from further spread of the parasite. However, complete
removal of the parasite is not guaranteed with surgery due to the
inﬁltrative nature of this infection, with recurrence rates reported to
be as high as 48%.2 Furthermore, surgical treatment may also lead to
complications such as disability and deformity.10
Radiotherapy has been proposed as a new treatment option for
bone hydatid disease and has the potential of being parasiticidal
while reducing the occurrence of disability and deformity. X-ray
irradiation has been shown to kill Echinococcus multilocularis
protoscoleces in vitro,11 while various rodent models of Echino-
coccus granulosus or E. multilocularis have shown that radiation can
kill or inhibit the growth of the parasite and cause cyst destruction
in a dose-dependent manner.12–15 Furthermore, there is also
clinical evidence that radiotherapy shows efﬁcacy in patients. In
1998, Schmid and colleagues reported that the use of gamma-knife
radiotherapy in a patient with inoperable cerebral hydatid disease
achieved shrinking of the cysts and that the patient’s condition was
stable after 3 years of follow-up, with improvements in the
neurological symptoms and quality of life.16 More recently, there
have been two other case reports describing the successful use of
radiotherapy for the treatment of bone hydatid disease.17–20 Thus,
radiotherapy for bone hydatid disease is currently receiving
attention as an alternative to surgery.
The objective of the present analysis was to observe the
treatment efﬁcacy and safety of surgery or radiotherapy in patients
diagnosed with bone hydatid disease.
2. Patients and methods
2.1. Study design and patients
This was a retrospective analysis of patients with bone hydatid
disease admitted to the orthopaedic centre of the First Afﬁliated
Hospital of Xinjiang Medical University between January 2000 and
December 2011. The number of cases during the study period
determined the sample size. Whenever the two treatment options
(surgery and radiotherapy) were possible in a patient, their
respective advantages and disadvantages were explained fully and
weighed against each other, and the patient was asked to make an
informed selection of his/her treatment option. Written informa-
tion leaﬂets were used in addition to medical counselling, and the
patients signed a treatment consent form when their decision had
been made. This consent form was approved by the Ethics
Committee of the First Afﬁliated Hospital of Xinjiang Medical
University in 2008. For the present retrospective case series,
individual consent was waived by the committee due to the
retrospective nature of the study.
Follow-up was scheduled for every 6 months.
2.2. Selection criteria
Study selection criteria were the following: (1) close contact with
sheep or dogs; (2) absence of cardiovascular or cerebrovasculardisease, or any other condition that would contraindicate surgery or
radiotherapy; (3) absence of conditions that may inﬂuence wound
healing and hardening of the skin (such as diabetes, nephrotic
syndrome, infectious diseases, psoriasis, and other skin diseases);
and (4) informed consent provided for treatment with surgery or
radiotherapy; this treatment consent form also allowed us to follow
the patient to assess the long-term effects of the treatment. In
addition, patients were included if they had bone hydatid disease
only and no other organ manifestations. Individuals with Echino-
coccus in other organs were excluded in order to eliminate the
possibility that other organs could be the source of recurrence after
surgery or radiotherapy.
2.3. Diagnosis
The differential diagnosis between bone tumours and bone
hydatid disease was based on a detailed patient history, clinical
symptoms, imaging investigations (X-ray, computed tomography
(CT), and magnetic resonance imaging (MRI)), and immunogold
analyses to determine serum levels of Echinococcus antibodies
(Ab).3,6,7,21 Hydatid disease was considered possible if imaging
showed severe bone destruction. A deﬁnitive diagnosis in patients
treated surgically was achieved after histopathological examina-
tion of biopsy tissue post-surgery.
2.4. Immunogold assay
A dot immunogold ﬁltration assay (DIGFA, Q/XZB Xin 00166-
2008; Xinjiang Beisiming Biotechnology Development Co. Ltd,
Urumqi, China), with a sensitivity of 97.5% and speciﬁcity of 97.5%,
was used for the deﬁnitive diagnosis of echinococcosis. The
following four antigen preparations were used to detect the
corresponding antibodies in the patient serum samples: EgCF
(E. granulosus cyst ﬂuid), EgP (E. granulosus protoscolex), EgB
(semi-puriﬁed hydatid cyst ﬂuid native antigen B), and Em2
(E. multilocularis for alveolar echinococcosis). The frozen serum
samples and kit reagents were thawed to room temperature (20–
25 8C) and processed in accordance with the manufacturer’s
recommendations. Positive and negative controls were included.
The titre was determined according to serial dilution of the
samples, using a semi-quantitative analysis. The results were
ranked on the basis of the colour of the ﬁnal product as follows:
negative, if the colour was poor or absent; +, if faint red; ++, if dark
red; and +++, if purple. Antibody titres were recorded at the time of
diagnosis and at 6 months after treatment.
2.5. Treatments
For the surgical treatment, localized complete lesion resection,
with or without fusion ﬁxation, was performed. Albendazole was
started 3 months before surgery and continued for 1 month after
surgery.
For radiotherapy, a medical electron accelerator (USA Varian
CX) was used to three-dimensionally locate lesions and then
irradiate the affected region at a dose of 6900 cGy, administered
23 times over 30 days. The total radiation dose was 75 Gy.
Radiotherapy of the lesions in bone tissues often resulted in
liquefaction of the necrotic tissue. To reduce the local pressure, the
tissues were punctured and the liquid extracted (Figure 4).
2.6. Parasitological outcomes
The patient response to treatment was monitored during
follow-up by physical examination, imaging, and immunochemical
analysis of serum samples and tissue biopsies. X-ray imaging was
used systematically as the primary imaging method for the
Table 1
Baseline characteristics of patients with bone hydatid disease
Surgery n = 24 Radiotherapy n = 16
Demographics
Male to female ratio 13:11 11:5
Age, years, mean  SD (range) 42.5  10.7 (26–57) 39.9  11.1 (25–55)
Infected bone (n)
Clavicle 4 4
Femur 1 1
Ilium 9 4
Rib 5 2
Sacrum 1 1
Spine 5 5
Disease duration, years, mean  SD 3.8  1.4 3.0  1.1
Follow-up period, years, mean  SD 5.1  2.9 3.9  0.7
SD, standard deviation.
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to evaluate treatment. The two groups of patients were asked to
attend the hospital for re-examination every 6 months after
treatment. Recurrence was determined according to physical
examination and imaging data.
2.7. Symptomatic outcomes
Patient satisfaction at 6 months after treatment was recorded at
interview and self-evaluated using a three-point scale as follows:
0, painful (relapse); 1, normal but feeling uncomfortable (sequel-
ae); and 2, satisﬁed (no relapse or sequelae). Patients with relapse
were assessed for their tolerance to surgery and their willingness
to undergo radiotherapy.
2.8. Treatment-induced morbidity
All treatment-induced morbidity (incapacitation due to treat-
ment, radiation-induced damage, sequelae) was assessed during
follow-up.
2.9. Statistical analysis
Descriptive statistics are presented, and were obtained using
SPSS version 17.0 software (SPSS Inc., Chicago, IL, USA). Differences
in results obtained pre- and post-treatment were analyzed using
the Wilcoxon rank sum test. p-Values of <0.05 were considered
signiﬁcant.
3. Results
3.1. Patient characteristics
Out of 40 patients with Echinococcus sp bone infections,
24 selected surgery and 16 selected radiotherapy. The demograph-
ic and baseline disease characteristics are presented in Table 1. At
baseline, the general health condition of most patients was poor,
and some even had cachexia. The bones that were infected were
the clavicle, femur, ilium, ribs, sacrum, and spine. The enclosed
masses at the lesion sites were often palpable. Some patients with
severe infection had fever. In some cases, the enclosed masses at
the lesion sites had ruptured, and this was accompanied by
purulent discharge, ﬁstula formation, hyper-pigmentation of the
surrounding skin, and limb movement dysfunction caused by
inﬁltration of the hydatids into joints and nerves.Figure 1. Radio-images of bone hydatid disease in the sacrum. A 37-year-old female pa
complicated with sacral sinus discharge of pus. After sacral hydatid surgery, MRI of the p
iliac bone, suggesting recurrence of sacral hydatid disease. Anteroposterior views of the p
of the sacrum and the right iliac bone (arrows). (C) Three-dimensional reconstruction of a
loss in the right ilium and sacrum, in a grid pattern.3.2. Baseline imaging data
At baseline, the affected regions showed bone destruction in all
patients (Figure 1), but the matrix, lacunae, and cells in the lacunae
were normal. Bone density was reduced, with the appearance of
multilocular cysts (Figure 1C). MRI revealed abnormal signals in
the affected bones (Figure 1A, B). In the CT scans, bone destruction
appeared in a ‘moth-eaten’ pattern and lesion areas in a ‘rat hole-
like’ pattern. Bone appeared sclerotic or showed cyst-like changes
(Figure 1C). Histological examination of biopsies of bone lesions
taken from patients in the surgery group conﬁrmed hydatid
infection (Figure 2A). Cyst ﬂuid was examined when possible
(Figure 2B).
3.3. Parasitological outcomes
Immunogold analysis revealed that the anti-Em2-Ab titres
remained unchanged post-treatment in both groups (Table 2). The
titres of anti-EgCF-Ab, anti-EgP-Ab, and anti-EgB-Ab decreased
post-treatment in the radiotherapy group, but increased signiﬁ-
cantly in the surgery group (Table 2).
There were 14 cases of relapse post-surgery (six cases of ilium
echinococcosis, three cases each of spinal hydatid and combined
sacral iliac spine echinococcosis, and one case each of femoral
echinococcosis and rib echinococcosis)(Figure 5). There were three
cases of relapse post-radiotherapy (two cases of combined sacral
iliac spine echinococcosis and one case of sacroiliac echinococco-
sis) (Table 3). There were no cases of osteoradionecrosis after
radiotherapy.tient was admitted with a 7-year history of postoperative sacral hydatid infection
elvic region (A and B) revealed abnormal signals from the sacral region and the right
elvis post-surgery showed: (A) sacral bone destruction (arrow), and (B) destruction
 CT scan obtained from a 33-year-old male patient, demonstrating bone damage and
Figure 2. (A) Histological section (haematoxylin and eosin staining) revealing Echinococcus granulosus (arrow). (B) Sacral hydatid cysts; cyst ﬂuid (arrow) was sampled for
analysis.
Table 2
Comparison of the levels of four serum antibodies in the patients from the surgery
and radiotherapy groups, before and 6 months after treatmenta
Antibody Surgery n = 24 Radiotherapy n = 16
Anti EgCF-Ab
Pre-treatment 20.92 19.88
Post-treatment 26.00 12.25
p-Value <0.05 <0.05
Anti EgP-Ab
Pre-treatment 21.58 18.88
Post-treatment 25.25 13.28
p-Value <0.05 <0.05
Anti EgB-Ab
Pre-treatment 22.10 18.09
Post-treatment 26.17 12.00
p-Value <0.05 <0.05
Anti Em2-Ab
Pre-treatment 21.00 19.75
Post-treatment 21.17 19.50
p-Value >0.05 >0.05
EgCF, Echinococcus granulosus cyst ﬂuid; EgP, Echinococcus granulosus protoscolex;
EgB, semi-puriﬁed hydatid cyst ﬂuid native antigen B; Em2, E. multilocularis for
alveolar echinococcosis.
a Data shown are medians of positively signed numbers.
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Post-surgery, bone loss was increased, but the bone matrix and
lacunae remained normal and hyperplasia of cells in the lacunae
was apparently active. Post-radiotherapy, deformation and disso-
ciation of the matrix mucilage and necrosis of some bone cells was
observed, concomitant with the initiation of osteogenesis
(Figure 3).
The overall satisfaction with treatment was signiﬁcantly higher
in the radiotherapy group compared to the surgery group (Table 3).Table 3
Comparison of treatment outcomes in the surgery and radiotherapy groups
Outcomes Surgery n = 24 Radiotherapy n = 16
Relapse, n (%)a 14 (58.3) 3 (18.7)
Sequelae, n (%)a 7 (29.2) 2 (12.5)
Patient evaluation, n (%)b
Painful 14 (58.3) 3 (18.8)
Uncomfortable 7 (29.2) 2 (12.5)
Satisﬁed 3 (18.8) 11 (68.8)
a Physical examination, imaging, and the immunogold test were used in the
follow-up to assess relapse and sequelae.
b Satisfaction with the treatment was self-evaluated by the patients at 6 months
post-treatment, on a three-point scale: painful (0), uncomfortable (1), or satisﬁed (2).3.5. Treatment-induced morbidity
Seven patients suffered from different degrees of sequelae after
surgery (Table 3). The main sequelae in the surgery group were
bone defects, limb movement disorders, and pain. One patient with
combined sacral iliac spine echinococcosis had numbness and
paralysis of lower limbs, two patients with ilium echinococcosis
had sciatic pain symptoms, and two patients with clavicle
echinococcosis and two patients with rib echinococcosis had
partial fractures.
After radiotherapy, two cases of sequelae were reported: one
patient showed hardening of the irradiated region while the other
had a limp (Figures 4 and 5).
4. Discussion
In this retrospective case series, we examined surgery and
radiotherapy as the treatment options for bone hydatid disease.
Although no direct comparison between treatment groups could be
made due to methodological limitations, this report characterizes,
for the ﬁrst time, the treatment and outcomes of a series of patients
treated with radiotherapy for bone hydatid disease. Outcomes as
evaluated by physical examination, imaging, and immunological
testing, appear promising for radiotherapy, indicating a high cure
rate. Importantly, satisfaction with treatment, as self-evaluated by
the patient, was high in the radiotherapy group. Thus, radiotherapy
holds promise for further evaluation as a potential alternative, or
adjunct treatment option to surgery in inoperable cases of bone
hydatid disease. However, prior to further treatment with radio-
therapy, well-designed randomized controlled clinical trials must be
performed to correctly assess the beneﬁts of radiotherapy compared
to surgery or medical treatment approaches.
In 2000, when we started offering radiotherapy as a
treatment option, there was only limited evidence that
radiotherapy may show efﬁcacy against Echinococcus.16 More
recently, there have been a number of animal studies and case
reports that have supported the use of radiotherapy for the
treatment of Echinococcus.12–15,17–20 Nonetheless, to date, there
has been no convincing evidence in the form of randomized
clinical trials to show that radiotherapy is an effective treatment
option.2 In view of the relative paucity of data in 2000, and since there
was no universally accepted standard of care for inoperable cases of
bone hydatid disease, it was decided that the most ethical approach to
offering this experimental treatment was to explain, impartially, the
relative advantages and disadvantages of radiotherapy to each patient
and allow him/her to make an informed decision as to whether he/she
would prefer radiation therapy or surgical intervention as the
treatment modality. The counselling was performed orally and with
written information leaﬂets; the Institutional Review Board approved
Figure 3. (A) X-ray image taken immediately after debridement and bone graft internal ﬁxation. (B) CT image taken 3 years post-radiotherapy, showing that the lesions had
ceased to expand; the grid-like structure appeared to be disordered and osteogenesis was occurring (arrow).
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Interestingly, out of the 40 patients included, 60% selected surgery
(24 patients) over radiotherapy (16 patients). Patients with bone
hydatid disease in the ilium or the ribs chose surgery (nine and ﬁve
patients, respectively) more often than radiotherapy (four and two
patients, respectively), whereas patients with infections in other bones
were represented equally in the two treatment groups (Table 1).
Levels of anti-Echinococcus antibodies are indicative of the
existence of hydatid disease. The post-treatment titres of anti-
EgCF-Ab, anti-EgP-Ab, and anti-EgB-Ab had decreased signiﬁcantly
in the radiotherapy group, but tended to increase in the surgery
group. Thus, if the levels of anti-Echinococcus antibodies are
considered to be an indicator of activity of hydatid disease,
radiation appears to be more effective than surgery. Other
explanations may include the potential of spillage and exposure
of hydatid ﬂuid to the immune system during surgical interven-
tion, whereas this is unlikely during radiotherapy. Although this
trend in antibody titres in the radiotherapy group is reassuring, it
should be emphasized that the study design of a case series does
not allow the direct comparison of the two approaches.Figure 4. Aspiration of necrotic hydatid tissue from a patient (male, 33 years old),
6 months after radiotherapy.Among the 24 patients in the surgery group, there were 14 cases
of relapse and seven cases of sequelae. We believe that this high
postoperative rate of relapse or sequelae was mainly related to the
fact that in cases of bone hydatids in the pelvis, spine, and femur,
the numerous arteries and nerves make it very difﬁcult to operate
and totally eliminate the parasite. Further, the possibility that
important nerves and blood vessels were damaged during surgery
cannot be excluded. Thus, there is a high chance of relapse and
sequelae. Operations on clavicle and rib bone hydatid disease are
relatively simpler, allowing total elimination of the lesion,
although resection of the lesion can cause local fractures.
Three-dimensional conformal, stereotactic imaging was used
for radiotherapy, and the radiation ﬁeld was selected according to
the size of the lesion, with the aim of limiting the damage to
surrounding tissues. The dose selected was suitable for human soft
and bone tissues, to avoid tissue necrosis and the formation of non-
healing lesions. Thus, highly localized irradiation prevented
dissemination of the parasite to other tissues. ImportantlyFigure 5. Relapse of hydatid disease was observed 15 days post-surgery; the
internal ﬁxation device was removed and debridement was repeated.
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effect may at least in part explain the lower rates of post-
interventional pain and sequelae. Two patients in the radiotherapy
group showed hardening of the irradiated region, which could be
because they were more sensitive to radiation than the other
patients. It is likely that these two patients would have been spared
these sequelae if a lower dose of radiation had been used.
The present study is not without limitations. First, the
retrospective design of this study did not allow the deﬁnitive
determination of whether radiotherapy is a useful treatment for
bone hydatid disease, or a deﬁnitive comparison of the efﬁcacy of
radiotherapy compared to that of surgery. This is primarily
attributable to the fact that self-decision on treatment modalities
does not allow for comparisons between groups and confounding
factors are therefore most likely not equally distributed. Moreover
treatment outcomes were assessed in a non-blinded way allowing
for the potential of assessor bias.
Due to these methodological limitations, larger-scale, prospec-
tive, randomized controlled trials with blinded outcome assess-
ment are needed to reliably establish the efﬁcacy of radiotherapy
and to determine the optimal dose and regimen for irradiation.
Further limitations include that echinococcosis was diagnosed
with certainty in only the surgery group, and not in the
radiotherapy group. Since biopsy runs the risk of causing spread
of the disease, it was decided that the diagnosis in the radiotherapy
group should instead be made on the basis of a history of close
contact with sheep and dogs, typical clinical manifestations,
imaging ﬁndings (X-ray, CT, and MRI), and immunogold analyses
to determine serum levels of Echinococcus antibodies. Nonethe-
less, we are conﬁdent that this combination did diagnose
echinococcosis in our patients effectively. Finally, patient satisfac-
tion may be inﬂuenced by confounding factors not accounted for in
the analysis. However, patient satisfaction, although subjective, is
a highly important clinical outcome parameter, and this supported
the notion of radiotherapy being a potential alternative treatment
modality for inoperable bone echinococcosis in the future.
In conclusion, this analysis provides information about the
clinical characteristics and outcomes of radiotherapy for hydatid
bone disease. Future well-designed studies may be warranted to
assess the potential of radiotherapy as an alternative or adjunctive
treatment in inoperable patients or in cases where medical
treatment has proved ineffective.
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